Department of Endocrinology and Metabolism and the Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, First Hospital of China Medical University, Shenyang, China.
Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, China.
Thyroid. 2024 Sep;34(9):1094-1104. doi: 10.1089/thy.2024.0286. Epub 2024 Aug 30.
Exposure to particles with an aerodynamic diameter of ≤2.5 μm (PM) is associated with the occurrence of thyroid dysfunction among pregnant women and neonates, but it is not known if this association occurs in the general population. We aimed to determine the association of prolonged exposure to PM with the prevalence of thyroid disorders among adults in China. A nationally representative cross-sectional study of thyroid disorders, iodine status, and diabetes status was carried out in all 31 provinces across China from 2015 to 2017. In total, 73,900 adults aged 18 years and older were included. Serum concentrations of thyroid hormones, thyrotropin, and thyroid antibodies and the urine iodine concentration were measured. The environmental concentration of PM for each participant's residential address at a spatial resolution of 1 × 1 km was estimated. The average long-term exposure to PM at residential addresses was 66.41 μg/m, ranging from 17.58 μg/m to 120.40 μg/m. Compared with that of individuals with lower exposure levels, the prevalence of thyroid diseases such as autoimmune thyroiditis and subclinical hypothyroidism was greater in those with PM concentrations within the third quartile range (60.18 to 73.78 μg/m). Compared with those in the first quartile (17.58 to 46.38 μg/m), participants in the highest PM quartile (73.78 to 120.40 μg/m) presented an increased risk of overt hypothyroidism (OR 1.23 [CI 0.94-1.61]), subclinical hypothyroidism (1.10 [1.01-1.21]), autoimmune thyroiditis (1.09 [1.00-1.18]), and thyroglobulin antibody positivity (1.17 [1.07-1.29]). However, there was no association between PM exposure and overt hyperthyroidism, subclinical hyperthyroidism, Graves' disease, or thyroid peroxidase antibody positivity ( > 0.05). Each 10 μg/m³ increase in the PM concentration was associated with an increased risk of overt hypothyroidism (OR 1.05 [1.00-1.11]), subclinical hypothyroidism (1.02 [1.00-1.03]), and thyroglobulin antibody positivity (1.02 [1.00-1.04]). Furthermore, a nearly linear exposure-response relationship was observed between long-term PM exposure and thyroglobulin antibody positivity. PM exposure was associated with thyroid disorders among Chinese adults. A dose-response relationship between PM exposure and autoimmune thyroiditis, as well as thyroglobulin antibody positivity, was also observed.
长期暴露于直径≤2.5μm 的颗粒物(PM)与孕妇和新生儿甲状腺功能障碍的发生有关,但目前尚不清楚这种关联是否存在于普通人群中。我们旨在确定 PM 长时间暴露与中国成年人甲状腺疾病患病率之间的关系。
2015 年至 2017 年,在中国 31 个省进行了一项全国性的甲状腺疾病、碘状况和糖尿病状况的横断面研究。共纳入 73900 名 18 岁及以上成年人。测量了甲状腺激素、促甲状腺激素和甲状腺抗体的血清浓度以及尿碘浓度。根据参与者居住地址的空间分辨率为 1×1km 来估算每个参与者的环境 PM 浓度。
长期居住地址的 PM 平均暴露水平为 66.41μg/m,范围为 17.58μg/m 至 120.40μg/m。与暴露水平较低的个体相比,处于 PM 浓度第三四分位范围内(60.18 至 73.78μg/m)的个体,自身免疫性甲状腺炎和亚临床甲状腺功能减退等甲状腺疾病的患病率更高。与第一四分位组(17.58 至 46.38μg/m)相比,处于 PM 四分位最高组(73.78 至 120.40μg/m)的参与者,患有显性甲状腺功能减退症(OR 1.23[94%CI 0.94-1.61])、亚临床甲状腺功能减退症(1.10[1.01-1.21])、自身免疫性甲状腺炎(1.09[1.00-1.18])和甲状腺球蛋白抗体阳性(1.17[1.07-1.29])的风险增加。然而,PM 暴露与显性甲状腺功能亢进症、亚临床甲状腺功能亢进症、格雷夫斯病或甲状腺过氧化物酶抗体阳性(>0.05)之间无关联。PM 浓度每增加 10μg/m³,与显性甲状腺功能减退症(OR 1.05[1.00-1.11])、亚临床甲状腺功能减退症(1.02[1.00-1.03])和甲状腺球蛋白抗体阳性(1.02[1.00-1.04])的风险增加相关。此外,在长期 PM 暴露与甲状腺球蛋白抗体阳性之间观察到几乎线性的暴露-反应关系。
PM 暴露与中国成年人的甲状腺疾病有关。PM 暴露与自身免疫性甲状腺炎以及甲状腺球蛋白抗体阳性之间也存在剂量-反应关系。